Literature DB >> 22272899

Association of platelet activation with vascular cognitive impairment: implications in dementia development?

Konstantinos Stellos, Niki Katsiki, Prokopia Tatsidou, Boris Bigalke, Christoph Laske1.   

Abstract

Cardiovascular risk factors are associated with coronary artery disease (CAD) and with cognitive dysfunction. However, the precise pathogenic mechanisms responsible for this association remain elusive. In the present study, CAD patients with cognitive impairment showed significantly higher platelet activation compared with CAD patients without cognitive impairment. In addition, we identified platelet activity to be a significant independent predictor for the severity of cognitive impairment in these patients. We discuss the link between platelet hyperactivity and dementia (including Alzheimer`s disease) based on the literature and our findings. We also discuss the potential mechanisms involved. This link may become a therapeutic option.

Entities:  

Mesh:

Year:  2014        PMID: 22272899     DOI: 10.2174/157016111201140327164641

Source DB:  PubMed          Journal:  Curr Vasc Pharmacol        ISSN: 1570-1611            Impact factor:   2.719


  8 in total

1.  Plasma microparticles in Alzheimer's disease: The role of vascular dysfunction.

Authors:  Soheila Hosseinzadeh; Maryam Noroozian; Esmaeil Mortaz; Kazem Mousavizadeh
Journal:  Metab Brain Dis       Date:  2017-12-05       Impact factor: 3.584

2.  Acetylcholinesterase inhibitors and risk of bleeding and acute ischemic events in non-hypertensive Alzheimer's patients.

Authors:  Faez Saleh Al-Hamed; Stamatis Kouniaris; Iskandar Tamimi; Marie Lordkipanidzé; Sreenath Arekunnath Madathil; Abbas Kezouh; Igor Karp; Belinda Nicolau; Faleh Tamimi
Journal:  Alzheimers Dement (N Y)       Date:  2021-08-20

3.  Coated-Platelet Trends Predict Short-Term Clinical OutcomeAfter Subarachnoid Hemorrhage.

Authors:  Bappaditya Ray; Vijay M Pandav; Eleanor A Mathews; David M Thompson; Lance Ford; Lori K Yearout; Bradley N Bohnstedt; Shuchi Chaudhary; George L Dale; Calin I Prodan
Journal:  Transl Stroke Res       Date:  2017-12-09       Impact factor: 6.829

4.  Heart disease as a risk factor for dementia.

Authors:  B Ng Justin; Michele Turek; Antoine M Hakim
Journal:  Clin Epidemiol       Date:  2013-04-26       Impact factor: 4.790

Review 5.  Heart failure and Alzheimer's disease.

Authors:  P Cermakova; M Eriksdotter; L H Lund; B Winblad; P Religa; D Religa
Journal:  J Intern Med       Date:  2014-08-01       Impact factor: 8.989

6.  Re-engineering a neuroprotective, clinical drug as a procognitive agent with high in vivo potency and with GABAA potentiating activity for use in dementia.

Authors:  Jia Luo; Sue H Lee; Lawren VandeVrede; Zhihui Qin; Sujeewa Piyankarage; Ehsan Tavassoli; Rezene T Asghodom; Manel Ben Aissa; Mauro Fà; Ottavio Arancio; Lan Yue; David R Pepperberg; Gregory R J Thatcher
Journal:  BMC Neurosci       Date:  2015-10-19       Impact factor: 3.288

Review 7.  Pathophysiology of blood brain barrier dysfunction during chronic cerebral hypoperfusion in vascular cognitive impairment.

Authors:  Vismitha Rajeev; David Y Fann; Quynh Nhu Dinh; Hyun Ah Kim; T Michael De Silva; Mitchell K P Lai; Christopher Li-Hsian Chen; Grant R Drummond; Christopher G Sobey; Thiruma V Arumugam
Journal:  Theranostics       Date:  2022-01-16       Impact factor: 11.556

8.  Exploring the potential of the platelet membrane proteome as a source of peripheral biomarkers for Alzheimer's disease.

Authors:  Laura E Donovan; Eric B Dammer; Duc M Duong; John J Hanfelt; Allan I Levey; Nicholas T Seyfried; James J Lah
Journal:  Alzheimers Res Ther       Date:  2013-06-13       Impact factor: 6.982

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.